Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Merck Serono and Opexa Therapeutics enter MS drug agreement

Feb. 6, 2013

The Medicines Company and Alnylam to develop therapeutics for hypercholesterolemia

Feb. 5, 2013

Japanese government provides funding for unoprostone isopropyl development

Feb. 5, 2013

Vernalis' drug discovery collaboration with Genentech yields milestone payment

Feb. 4, 2013

Teva Pharmaceutical terminates agreements with CureTech

Feb. 4, 2013

Pharmaxis provides update on Bronchitol

Feb. 1, 2013

Phylogica receives milestone payment under collaboration with Janssen Biotech

Feb. 1, 2013

Ezose Sciences enters glycomics research agreement

Feb. 1, 2013

Italian hospital to conduct phase I/II trial of DPX-0907

Feb. 1, 2013

New collaboration on serological peptide markers for diagnosis of CFS

Jan. 31, 2013

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...